Immune damage may explain ineffectiveness of high-dose radiation against lung cancer

(University of Colorado Anschutz Medical Campus) study finds 14.3 month vs. 28.2 month median survival for high- vs. low-dose radiation in patients with stage III non-small cell lung cancer.